Vasoplegic syndrome following cardiothoracic surgery-review of pathophysiology and update of treatment options. [electronic resource]
- Critical care (London, England) 02 2020
- 36 p. digital
Publication Type: Journal Article; Review
1466-609X
10.1186/s13054-020-2743-8 doi
Adrenal Cortex Hormones--therapeutic use Angiotensin II--therapeutic use Ascorbic Acid--therapeutic use Cardiac Surgical Procedures--adverse effects Dopamine--therapeutic use Enzyme Inhibitors--therapeutic use Epinephrine--therapeutic use Humans Methylene Blue--therapeutic use Norepinephrine--therapeutic use Phenylephrine--therapeutic use Sympathomimetics--therapeutic use Vascular Resistance--drug effects Vasoconstrictor Agents--therapeutic use Vasoplegia--drug therapy Vasopressins--therapeutic use